Vif-CBFβ interaction is essential for Vif-induced cell cycle arrest.

Area of Science:

• Virology
• Cell Biology
• Immunology

Background:

• HIV-1 Vif protein hijacks host ubiquitin ligase complexes to degrade APOBEC3 restriction factors, promoting viral replication.
• Vif also induces G2/M cell cycle arrest, enhancing HIV-1 replication and contributing to CD4+ T-cell depletion.
• The role of host factor CBFβ in Vif-mediated G2 arrest was previously unknown.

Purpose of the Study:

• To investigate the involvement of CBFβ in Vif-induced G2 cell cycle arrest.
• To determine if the interaction between Vif and CBFβ is critical for Vif's cell cycle regulatory functions.
• To explore potential therapeutic strategies targeting the Vif-CBFβ interaction.

Main Methods:

• Quantitative analysis of CBFβ expression and its effect on Vif-induced G2 arrest.
• Site-directed mutagenesis to assess the importance of Vif-CBFβ interaction.
• Investigation of the role of E3 ubiquitin ligase complex and proteasome in Vif-induced G2 arrest.

Main Results:

• CBFβ is essential for Vif to induce G2 arrest; reducing CBFβ levels significantly impairs Vif's cell cycle regulation.
• The interaction between Vif and CBFβ is crucial for Vif to induce G2 arrest.
• Inhibition of the Vif-hijacked E3 complex or proteasome-mediated degradation also blocks Vif-induced G2 arrest.

Conclusions:

• CBFβ is a critical host factor required for Vif-induced G2 arrest, likely through the depletion of an unknown cellular target.
• Antiviral therapies targeting the Vif-CBFβ interaction could simultaneously inhibit Vif's ability to degrade APOBEC3 proteins and induce G2 arrest.
• Such therapies hold promise for reducing HIV-1 replication and mitigating Vif-associated CD4+ T-cell depletion.